Suppr超能文献

非医用大麻合法化与酒类销售的关联:来自加拿大的准实验证据。

Association between non-medical cannabis legalization and alcohol sales: Quasi-experimental evidence from Canada.

机构信息

College of Pharmacy, University of Manitoba, Winnipeg, Canada.

School of Pharmacy, Memorial University of Newfoundland, St. John's, Canada.

出版信息

Drug Alcohol Depend. 2024 Apr 1;257:111137. doi: 10.1016/j.drugalcdep.2024.111137. Epub 2024 Feb 27.

Abstract

BACKGROUND

There is increasing interest in understanding the impact of non-medical cannabis legalization on use of other substances, especially alcohol. Evidence on whether cannabis is a substitute or complement for alcohol is both mixed and limited. This study provides the first quasi-experimental evidence on the impact of Canada's legalization of non-medical cannabis on beer and spirits sales.

METHODS

We used the interrupted time series design and monthly data on beer sales between January 2012 and February 2020 and spirits sales between January 2016 and February 2020 across Canada to investigate changes in beer and spirits sales following Canada's cannabis legalization in October 2018. We examined changes in total sales, nationally and in individual provinces, as well as changes in sales of bottled, canned and kegged beer.

RESULTS

Canada-wide beer sales fell by 96 hectoliters per 100,000 population (p=0.011) immediately after non-medical cannabis legalization and by 4 hectoliters per 100,000 population (p>0.05) each month thereafter for an average monthly reduction of 136 hectoliters per 100,000 population (p<0.001) post-legalization. However, the legalization was associated with no change in spirits sales. Beer sales reduced in all provinces except the Atlantic provinces. By beer type, the legalization was associated with declines in sales of canned and kegged beer but there was no reduction in sales of bottled beer.

CONCLUSIONS

Non-medical cannabis legalization was associated with a decline in beer sales in Canada, suggesting substitution of non-medical cannabis for beer. However, there was no change in spirits sales following the legalization.

摘要

背景

人们越来越关注了解非医用大麻合法化对其他物质(尤其是酒精)使用的影响。关于大麻是酒精的替代品还是补充品的证据既有混合的,也有限的。本研究提供了加拿大非医用大麻合法化对啤酒和烈酒销售影响的首个准实验证据。

方法

我们使用了中断时间序列设计和 2012 年 1 月至 2020 年 2 月期间加拿大各地的啤酒销售月度数据以及 2016 年 1 月至 2020 年 2 月期间的烈酒销售月度数据,以调查加拿大 2018 年 10 月大麻合法化后啤酒和烈酒销售的变化。我们考察了全国和个别省份的总销售额的变化,以及瓶装、罐装和桶装啤酒的销售额变化。

结果

加拿大全国范围内,啤酒销售量在非医用大麻合法化后立即下降了 96 公升/每 10 万人(p=0.011),此后每月下降 4 公升/每 10 万人(p>0.05),平均每月减少 136 公升/每 10 万人(p<0.001)。然而,合法化与烈酒销售没有变化有关。除了大西洋省份外,所有省份的啤酒销售量都有所下降。按啤酒类型划分,合法化与罐装和桶装啤酒销售量下降有关,但瓶装啤酒销售量没有减少。

结论

非医用大麻合法化与加拿大啤酒销售量下降有关,表明非医用大麻替代了啤酒。然而,合法化后烈酒销售量没有变化。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验